DUBLIN, IRELAND--(Marketwire - 07/13/09) - In the news release, "Trinity Biotech plc to Announce Second Quarter 2009 Financial Results on July 23, 2009" issued earlier today by Trinity Biotech (NASDAQ:TRIB - News), we are advised by the company that the date in the subheadline should read "July 23" rather than "July 13" as originally issued. Complete corrected text follows.

Trinity Biotech plc to Announce Second Quarter 2009 Financial Results on July 23, 2009

Conference Call Scheduled for July 23, 2009 at 11:00 am EASTERN

DUBLIN, IRELAND -- July 13, 2009 -- Trinity Biotech plc (NASDAQ:TRIB - News), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter of 2009 on Thursday, July 23, 2009. The Company has scheduled a conference call for that same day, Thursday, July 23, 2009, at 11:00am ET (4:00pm BST) to discuss the results of the quarter.

Interested parties can access the call by dialing:

 
     USA:           1-800-860-2442
     International: 1-412-858-4600

A simultaneous webcast of the call can be accessed at: http://www.videonewswire.com/event.asp?id=60389

A replay of the call can be accessed until July 27, 2009 by dialing:

 
     USA:                1-877-344-7529
     International:      1-412-317-0088
     Conference ID #:    432266

The webcast of the call will be available for 30 days at: http://www.videonewswire.com/event.asp?id=60389

About Trinity Biotech plc

Headquartered in Wicklow, Ireland, Trinity Biotech develops, acquires manufactures and markets over 500 diagnostic products for the point-of-care and clinical laboratory segments of the diagnostic market. The broad line of test kits are used to detect infectious diseases, sexually transmitted diseases, blood coagulation disorders, and autoimmune diseases. Trinity Biotech sells worldwide in over 80 countries through its own sales force and a network of international distributors and strategic partners.

For further information please see the company's website: http://www.trinitybiotech.com.

 
Contact:
Mr. Kevin Tansley
Chief Financial Officer
Trinity Biotech plc
353-1-2769800
Joe Diaz, Joe Dorame and Robert Blum
Lytham Partners, LLC
602-889-9700